1 2 3 4 5 6 7 8 9
далее York 2001 p210 3 O'Duffy JD, Carney JA, Deodhar S S Behcet s disease Ann Inter Med , 1971, 75 561-570 4 Evereklioglu C Current concepts in the etiology and treatment of Behcet's disease Surv Ophthalmol 50(4) July-August 2005, 297-350 5. Mat С Yurdakul S , Uysal S et al A double-blind trial of depot corticosteroids in Behcet s syn drome Rheumatol (Oxford) 2006 Mar, 45(3) 348-352 6 Kaklamani VG, Kaklamanis PG Treatment of Behcet's disease-an update Semm Arthritis Rheum 2001 Apr. 30(5) 299-312 7 Pronai L Ichikawa Y, Nakazawa H et al Enhanced-superoxide generation and the decreased superoxide scavenng activity to peripheral blood leukocytes in Behcet's disease - effects of colchicine Clin Exp Rheumatol 1991, 9(3), 227-233 8 Assad-Khalil S , Ghanem Y , EL Masry A et al Retrospective evaluation of some commonly used therapeutic agents in Behcet's disease Behcet's disease Proc of the Intern Conference on Behcet's disease Seoul, Korea, 27-29 May, 2000 p 439-445 9 Yazici H , Barnes S Practical treatment recommendation for pharmacomerapy of Behcet's syn drome Drag 1991,42 796-804 10YaziciH A critical appraisae of therapy of Behcet's disease Proced of the 8th Intern Conference on Behcet s disease Held in Reggio Emilia Italy, October 7-9, 1998 p 895 11 Yazici H , Pazarli H , Barnes С et al A controlled trial of azathiopnne in Behcet's syndrome NEnglJMed 1990,322 139 141 12 Hamuryudan V Ozyargan Y, Hlzli N et al Azathiopnne in Behcet's syndrome effects on long-term prognosis Arthr Rheum , 1997, 40 769-774 13 Davatchi F, Shahram F, Chams H et al Azathiopnne for the treatment of ophthalmological lesions of Behcet's disease 10th International Conference on Behcet's disease Berlin June 27-29 2002 p 898 14 Ermakova N A Comparative evaluation of the effectivenes of corticosteroids and cytostates in treating retinal angiitis in Behcet's disease Vestn Ophthalmol 2002,118 32-35 15 Feron EJ, Rothova A van Hagen PM et al Interferon-a 2a for refractory ocular Behcet's dis ease Lancet 1994,343 1428 16 Kotter I, Dork H, Eckstein A Erosive arthritis and posterior uveitis in Behcei's disease Treatment with interferon-a and interferon-y Clin Exp Rheumatol 1996, 14 113-115 17 Kotter I Eckstein AK, Stubiger N, Zierhut M Treatment of ocular symptoms of Behcet's disease With interferon-a 2a a pilot study Br J Ophthalmol 1998,82 488-494 18 Alpsoy E , Durusoy С , Yilmaz E Interferon alfa-2a in the treatment of Behcet's disease a randomized placebo-controlled and double-blind study ArchDermatol 2002, 138 467-471 19 Kotter I, Zierhut M Eckstein AK Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis Br J Ophthalmol 2003,87 423-431 20 Hamuryudan V, Moral F , Yurdakul S Systemic mterferon-a-2a treatment in Behcet's syndrome J Rheumatol 1994 21 1098-1100 21 Kotter I, Vonthein R , Zierhut M Differential efficacy of human recombinant interferon-a 2a on ocular and extraocular manifestations of Behcet's disease results of далее ...